Appendix cancer other imaging findings

Jump to navigation Jump to search

Appendix cancer Microchapters


Patient Information


Historical Perspective




Epidemiology and Demographics

Differentiating Appendix cancer from other Diseases

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings




CT scan

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Appendix cancer other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Appendix cancer other imaging findings

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Appendix cancer other imaging findings

CDC on Appendix cancer other imaging findings

Appendix cancer other imaging findings in the news

Blogs on Appendix cancer other imaging findings

Directions to Hospitals Treating Appendix cancer

Risk calculators and risk factors for Appendix cancer other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]


Positron emission tomography (PET) and scintigraphy are among other imaging modalities that may be helpful in the diagnosis and management of appendix cancer.

Other Imaging Findings

Appendiceal adenocarcinoma complicated by retroperitoneal abscess. Post-operative PET-CT scan shows high uptake posterior to the cecum, suspicious for residual tumor and/or peritoneal carcinomatosis. Case courtesy of Dr Francis Fortin, <a href=""></a>. From the case <a href="">rID: 58007</a>


  1. Kisker O, Bartsch D, Weinel RJ, Joseph K, Welcke UH, Zaraca F et al. (1997) The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors. J Am Coll Surg 184 (5):487-92. PMID: 9145069
  2. 2.0 2.1 Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL et al. (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86 (2):895-902. DOI:10.1210/jcem.86.2.7194 PMID: 11158063
  3. Sundin A, Eriksson B, Bergström M, Långström B, Oberg K, Orlefors H (2004) PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci 1014 ():246-57. PMID: 15153441

Template:WH Template:WS